1. Home
  2. VRME vs BCDA Comparison

VRME vs BCDA Comparison

Compare VRME & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.70

Market Cap

11.0M

Sector

Technology

ML Signal

HOLD

BCDA

BioCardia Inc.

HOLD

Current Price

$1.12

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
BCDA
Founded
1999
N/A
Country
United States
United States
Employees
30
21
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0M
12.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VRME
BCDA
Price
$0.70
$1.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$1.50
$25.00
AVG Volume (30 Days)
55.6K
105.1K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$1.00
52 Week High
$1.51
$2.49

Technical Indicators

Market Signals
Indicator
VRME
BCDA
Relative Strength Index (RSI) 31.07 43.44
Support Level $0.64 $1.10
Resistance Level $0.93 $1.30
Average True Range (ATR) 0.05 0.05
MACD -0.01 -0.00
Stochastic Oscillator 17.89 38.86

Price Performance

Historical Comparison
VRME
BCDA

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: